Methods for treating pruritus

An anti-pruritic and drug technology, applied in pharmaceutical formulations, medical preparations with inactive ingredients, and medical preparations containing active ingredients, etc.

Inactive Publication Date: 2019-12-20
TREVI THERAPEUTICS
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The cause of the itching is not fully understood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for treating pruritus
  • Methods for treating pruritus
  • Methods for treating pruritus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-3

[0214] Three sustained release delivery systems were prepared by dry blending xanthan gum, locust bean gum, calcium sulfate dihydrate, and mannitol in a high speed mixer / granulator for 3 minutes. While the chopper / impeller was running, the dry blend was sprayed with water and regranulated for 6 minutes. The granulation process was then stopped and the mixer / granulation disk removed. While running the chopper / impeller, mix the granules for an additional 1 minute. After checking the consistency of the granules, while running the chopper / impeller, add additional water to the granules and re-granulate for 3.5 minutes. The granules are then dried to a LOD (loss on drying) of less than about 4 wt%. The granules were then ground using a No. 1521-0033 sieve. The relative amounts of the ingredients are listed in Table 1.

[0215] Table 1

[0216]

[0217]

Embodiment 4-7

[0219] A series of tablets containing different amounts of gum were prepared using the sustained release delivery system of Example 3. The amounts of ingredients per tablet are listed in Table 2.

[0220] Table 2

[0221]

[0222] Tablets are prepared by mixing nalbuphine and the sustained release delivery system in a mixer. The magnesium stearate was passed through a #30 mesh separator screen and then mixed with the dry blend containing nalbuphine and the sustained release delivery system. The lubricated blend was compressed using the dies specified in Table 2 to yield tablets with the indicated total weight.

[0223] The tablets of Examples 4-7 were tested for in vitro % release rate according to USP Procedure Drug Release General Chapter Dissolution using an instrument USP Type III / 250 mL. The test was performed in 100 mM ammonium phosphate buffer at pH 6.8, 37°C. / 15 dpm (dips per minute). The results are shown in Table 3.

[0224] table 3

[0225]

[0226] ...

Embodiment 8-10

[0228] A series of tablets containing different amounts of gum and different sustained release delivery systems were prepared using the sustained release delivery systems of Examples 1 and 2. The amounts of ingredients per tablet are listed in Table 4.

[0229] Table 4

[0230]

[0231] Tablets were prepared by first mixing nalbuphine with the sustained release delivery system in the mixer of example 8 and in the high shear granulator of examples 9 and 10. For Examples 9 and 10, the blend was then granulated with water until consistent granules were obtained, followed by drying in a fluid bed dryer at 70°C for 30 minutes. The dried granules were then passed through a Fitzmill using a 1521-0050 sieve at 2500 rpm. Magnesium stearate was passed through a #30 mesh screen, then mixed with the pulverized granules of Examples 9 and 10 and with the dry blend of Example 8 for 5 minutes. The lubricated blend was compressed using the dies specified in Table 4 to yield tablets with ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to methods for treating pruritus. According to the method, an effective amount of anti-pruritus drugs is provided for a patient, who needs to be treated, wherein the anti-pruritus drugs can be nalbuphine or pharmaceutically acceptable salts or esters.

Description

[0001] This application is a divisional application of an invention patent application with an application date of December 13, 2013, an application number of 2013800725423, and an invention title of "Method for Treating Pruritus". [0002] related application [0003] This application claims priority to U.S. Provisional Application No. 61 / 737,488, filed December 14, 2012, and U.S. Application No. 13 / 715,625, filed December 14, 2012, which are hereby incorporated by reference in their entirety . technical field [0004] The present invention relates to methods of treating pruritus with antipruritic compositions. Background technique [0005] Pruritus or itch is a sensation that stimulates the desire or reflex to scratch, which can be generalized or localized. The cause of itching is not fully understood. Factors proposed to contribute to the pathogenesis of pruritus may include anemia or other manifestations of erythropoietin deficiency, histamine release from cutaneous m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): A61K31/485A61K9/20A61K47/38A61P17/04A61P17/00A61P17/06A61P17/08
CPCA61K31/485A61P1/00A61P1/16A61P13/12A61P15/08A61P17/00A61P17/04A61P17/06A61P17/08A61P17/10A61P25/00A61P35/00A61P37/08A61P3/10
InventorT·夏夏
OwnerTREVI THERAPEUTICS